Skip to content

Public FDA record

Z-0463-2013: Sekisui Diagnostics, Spectrolyse PAI-1 In-Vitro Diagnostic Use for the quantitative determination of Pla

Recall record Z-0463-2013 for Sekisui Diagnostics Llc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0463-2013
Company in FDA record
Sekisui Diagnostics Llc
FDA classification date
Dec 3, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

Spectrolyse PAI-1 activity assay, producing lower than expected absorbance values 0 IU/ml standard reducing the slope of the standard curve requiring more frequent sample dilutions.

Source facts

Action
Sekisui Diagnostics issued an "URGENT PRODUCT RECALL NOTICE" dated October 24, 2012 to all consignees. The letter instructed consignees to immediately stop using the specified lot of product, discard any remaining inventory and return the enclosed response form. Contact the Customer Service Department at 800-637-3375, ext. 10, 12, or 31 for assistance with this recall.
Initiated
2012-10-24
Root cause
Nonconforming Material/Component
Terminated
2013-01-08
Distribution
Nationwide Distribution-including the states of FL, IN, NC, OH, UT, and WA.
Recall number
Z-0463-2013
Recall status
Terminated
CDRH record ID
114366
FDA classified
2012-12-03
Recall event number
63615

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗